PRE-MOTOR PARKINSON DISEASE
Clinical trials for PRE-MOTOR PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRE-MOTOR PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for PRE-MOTOR PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug tested to halt Parkinson's before symptoms start
Disease control OngoingThis study is testing whether a medication called carvedilol, commonly used for heart conditions and high blood pressure, can slow down the brain changes that lead to Parkinson's disease. It involves 15 people who are at high risk for Parkinson's because they have a specific slee…
Matched conditions: PRE-MOTOR PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Heart drug trial aims to halt Parkinson's before symptoms start
Disease control OngoingThis study is testing if a common heart medication, carvedilol, can slow or prevent the progression of Parkinson's disease in people at high risk. It focuses on individuals with a specific sleep disorder (REM sleep behavior disorder) and other early warning signs. Researchers wil…
Matched conditions: PRE-MOTOR PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Michele Tagliati, MD • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC